Diagnostic and therapeutic value of intracellular biomarker testing in chronic pain

Pain Manag. 2024 Jan;14(1):21-27. doi: 10.2217/pmt-2023-0080. Epub 2024 Jan 9.

Abstract

Aim: Micronutrient and metabolic compound supplementation as a method of treating chronic pain is not well understood. Case: A 58 year-old woman presented with refractory painful neuropathy. She did not respond to conservative treatment and was seeking spinal cord stimulator implantation. She underwent a biomarker panel that revealed low intracellular levels of multiple compounds. As she supplemented her deficiencies, her symptoms fully resolved, and the implant was no longer indicated. Discussion: Micronutrient and metabolic compound testing could potentially expand non-invasive treatment options for patients with refractory chronic pain. Caution should be exercised given limited regulatory oversight in the supplement industry and actively ongoing nutritional research. Conclusion: Biomarker testing panels may be a useful adjunct in the management of refractory neuropathic pain.

Keywords: chronic pain; metabolic compounds; micronutrients; neuropathic pain; peripheral neuropathy.

Publication types

  • Case Reports

MeSH terms

  • Chronic Pain* / diagnosis
  • Chronic Pain* / therapy
  • Electric Stimulation Therapy*
  • Female
  • Humans
  • Micronutrients
  • Middle Aged
  • Neuralgia* / diagnosis
  • Neuralgia* / therapy
  • Pain Management
  • Pain, Intractable*

Substances

  • Micronutrients